РОСЗДРАВНАДЗОР Информационное письмо № 16И-781/13 от 18.07.2013
РОСЗДРАВНАДЗОР Информационное письмо № 16И-781/13 от 18.07.2013
ФЕДЕРАЛЬНАЯ СЛУЖБА ПО НАДЗОРУ В СФЕРЕ ЗДРАВООХРАНЕНИЯ (РОСЗДРАВНАДЗОР)
109012, Москва, Славянская пл. 4, стр. 1, Телефон: 8(495)698-45-38; 8(495)698-15-74 https://roszdravnadzor.gov.ru
Информационное письмо № 16И-781/13 от 18.07.2013
О лекарственном средстве «Дакоген»
MnxucrepcrBo sApaBooxpaneHnfl
Poccnficrofi rDe4epaqun
aE,[EPA]IbHAfl CJIy}I(SA IIO HAA3OPy
B COEPE 3APABOOXPAHEHT,TS
(POC3APABHA,TISOP)
Cy6rerraM o6pauleHr.rt
w. 4, crp. l,
Mocxra, 109074
Teaerlon: (495) 698 45 38;698 t5 74
CJrassHcKa.s
Ne-
JIeKapcTBeHHbrx cpeAcTB
/Czc -
OT
O nerapcrneunoM cpeAcrBe
<,{arcoren>
(De4epzurrnar cJryxda no HaA3opy B cQepe 3ApaBooxpa*enns,
AoBoAur Ao
cBeAeHI{t cy6seKToB o6palqeHl{rl JreKapcrBeHHbx cpeAcrB rr]rcbMo OOOAxoscoru c IlHQopMaIIEefi 06 ycJroBt4fx xpaHeHuf, Jrer(apcrBeHHoro npenapara
(AaKoreH, ruo$uJll43ar AJII npriroroBJrenr,rr KoHrIeHTpara
Arrfl npuroroBJreHr4.f,
pacrBopa AJrf, r,rHoysuft 50 Mf).
flpznoxeHr.re: Ha
I r. s I ers.
Bpuo pyKoBoAureJr.fl
14.A.EnarlrHa
8 (499) s7802-19
M.A.MyparrrKo
fil2t6L4, Moscow, Krylatskaya *r., t7, building 2,
L2I6l4, Mocxaa, yn. Kpunarcraa, t7, c:ip.2
Ten.: (495) 72655 55, Qaxc: (495) 580 90 29
Tel.: (495) 726 55 55, fax:(495) 580 90 29
HloHu 2013
KaraxcraH/Poccllc
llpu.noxeune
l.
llHQopnraql{oHnoe nucbMo AJrfl crrerlnaJrucroB s o6racru 3ApaBooxpaHeggfl
Vc;ronus xpaHeHufl JrerapcrBeHuoro [pe[apara laxoreH
I-{enrrc AaHHoro tIHcbMa r.Blrflercfl, npeAocraBneHr,re Bilr(Hoft uH{opuaqun o6 ycnoBgrx xpaHeHHt
neKapcrBeHHoro [penapara AIrfl MeAr.rrIHHcKofo rtpHMeHeHHq laxoreH, .rruoSulurar
AM
rlpHroroBneHl,It KoHIIeHrpara Anr npr,rroroBreHr,rq pacrBopa 4nx r.ru$ysufi, 50 ur. HeAasHo OOO
6ula ycraHoBneHa Heo6xo4r,rMocrb yroqHeHr,rc ycnonnft xpaHeHr,rt
AaHHOTO npelapara, yKa3aHHbIX B yrBep)KAeHHbrx perHcrparlfioHHbrx AoKyMeHTax. Ha
AasHufi
MoMeHT B HHcrpyKrIHH rro MeAHrIuHcKoMy npnMeHeHr,rro yKa3aHo, rrro He ncrpurrrfi
Qlarcon c
rpenaparoM cneAyer xpaHl{rb rIpH TeMneparype l5-30"C. OAHaro 6ruro ycraHoBJreHo, qro rrperapar
cneAyer xpaHI'ITb rIpI4 reMrleparype He Bbrrle 25"C. OOO <{xoucoH &
lxoncou>
npor.rHSopMlrpoBirno o6 erou @elepalrnyro Cnyx6y rro HaA3opy cSepe 3.qpasooxpaneHur.
Tarxe
6ruo rIoAaHo 3iuIBneHI'Ie s M[HucrepcrBo 34panooxpaneHur Ha BHeceHHe coorBercrBvroru'X
ugureHenufi
B
perucrparlr{oHHbre AoKyN{eHTbr.
o Eclu
yc|roBwfl, xpaneHut neKapcrBeHHoro [penapara
{aroreu He coorBercrByr.or ycnoBr{ro
syulecrByer Bo3MoxHocrb cHr.rxeHu,
o
KoJlnqecrBa Aerlu'ra6uHa B flpenapare lt rIoBbIIIreH[r Konl{qecrBa
[poAyKToB ero pi3noxeHgr.
Bo BHI{MaHI'Ie He6olsruyro [poAonxr.rreJrbHocrb xpaHeHrrr rrpe[apara
BHe cKJIaAa
KoMnaHI4H oooHa KoropoM npoBoAuTcc
flpnnuMitt
lxoncoH>
rocrorHHrrfi roHrpo6
TeMneparypbl u TeMlleparypa [oAAepxHBaercr Hr{xe 25"C, BeporrHocrb
roro, r{To
neKapcrBeHuufi upenapar xpanl'ITcf, npu reMneparype, npeBbuuarcueft
25"C,Hn3Kuur.
r Ha ocHoBaHHI'I rpoBeAeHHoro aHaJrr.r3a BHyrpesuefi 6a:rr
AaHHbx OOOflxoucou> He BHAHT Bo3Mo)KHoro r,rvraHat Ha npo$unr 6esonacHocru rrpelapara.
Percorrengaqfin cneqfllurrcrau o6;racTrr 3ApaBooxpaHeH[s:
o flocrcolrry ooo
o
xpaHr,rnc,
rIpI{ TeMrleparype Hltxe 25"C lo MoMeHTa AocraBKLI B MeAfirlr{HcKoe {axoreu
yqpexreg1ae r.rJrr.r B
aIITeKy' He oxl'IAaerct I'I3MeHeHHe Ha npo0unx 6egouacHocrr.r
neKapcrBeHuoro lpe[apara.
B roM cJlyr{ae, ecJIIr BsI He yBepeHbl, qro neKapcrseHHHft rrpelapar xpaHr.rnc,
np'
reMreparype He BbIIrIe 25oC rrarr [pocI.IM Bac csrgarrcs c OOO
<
(ren': +7 (495) 755-83-57, Sarc: +7 (495) 755-83-58)
arx .ur""r, neKapcrBeHHoro
tIpeuapara.
,{aunoe IIHcbMo ony6luronaHo no cofnacoBaHuro c OeAepalruoft Cnyx6oft no
HaA3opy n cQepe
3.qpasooxpaHeHns
Poccuftcxoft Oeaepaqur.r.
Horvrep re.ne$ona,r.nn
coo6qennft o HexeJrareJrbHbrx
fl
BJreH[sx
s o6ractn 3ApaBooxpalelvs. cneAyer coo6qarr o mo6rx HexeJrarenbHbx
tBJreHrrrx' cBr3aHHb\rNc
Cnequalxcrau
npHeMOM
121614, Mocxna,
(49s)
npelapara,{axoreH, s OOO <,,{xoHcoH &
!xoncoH>), pOCCl1g,
re.neQoubr: rerr.: +7 (4gS) 755-g3-57,
eaxc: +7
yl' $unarcrar, I i/2, not u*rnue
7s5-S3-s8 \\
flpn norHuxHoseHHu\bon
c ynaxeHueu, lf\ $
fleHncona H.A., \\\ J
o6parr{arrca no rereSoHy +7 (495) 755-g3-57
Meuegxep rtu
rvrlnvA^,l\sp
no ug3ollacHogJm
6eronac"on)d npeIIapaToB
OOO <{xoHcoH & nxon'oori>Limited Liability Company Johnson & Johnson
O6u{ecreo c orpaHhqeHHofi oreercraexHocrb|o <& AxoHcoxr
Poccnficrofi rDe4epaqun
aE,[EPA]IbHAfl CJIy}I(SA IIO HAA3OPy
B COEPE 3APABOOXPAHEHT,TS
(POC3APABHA,TISOP)
Cy6rerraM o6pauleHr.rt
w. 4, crp. l,
Mocxra, 109074
Teaerlon: (495) 698 45 38;698 t5 74
CJrassHcKa.s
Ne-
JIeKapcTBeHHbrx cpeAcTB
/Czc -
OT
O nerapcrneunoM cpeAcrBe
<,{arcoren>
(De4epzurrnar cJryxda no HaA3opy B cQepe 3ApaBooxpa*enns,
AoBoAur Ao
cBeAeHI{t cy6seKToB o6palqeHl{rl JreKapcrBeHHbx cpeAcrB rr]rcbMo OOO
(AaKoreH, ruo$uJll43ar AJII npriroroBJrenr,rr KoHrIeHTpara
Arrfl npuroroBJreHr4.f,
pacrBopa AJrf, r,rHoysuft 50 Mf).
flpznoxeHr.re: Ha
I r. s I ers.
Bpuo pyKoBoAureJr.fl
14.A.EnarlrHa
8 (499) s7802-19
M.A.MyparrrKo
fi
L2I6l4, Mocxaa, yn. Kpunarcraa, t7, c:ip.2
Ten.: (495) 72655 55, Qaxc: (495) 580 90 29
Tel.: (495) 726 55 55, fax:(495) 580 90 29
HloHu 2013
KaraxcraH/Poccllc
llpu.noxeune
l.
llHQopnraql{oHnoe nucbMo AJrfl crrerlnaJrucroB s o6racru 3ApaBooxpaHeggfl
Vc;ronus xpaHeHufl JrerapcrBeHuoro [pe[apara laxoreH
I-{enrrc AaHHoro tIHcbMa r.Blrflercfl, npeAocraBneHr,re Bilr(Hoft uH{opuaqun o6 ycnoBgrx xpaHeHHt
neKapcrBeHHoro [penapara AIrfl MeAr.rrIHHcKofo rtpHMeHeHHq laxoreH, .rruoSulurar
AM
rlpHroroBneHl,It KoHIIeHrpara Anr npr,rroroBreHr,rq pacrBopa 4nx r.ru$ysufi, 50 ur. HeAasHo OOO
AaHHOTO npelapara, yKa3aHHbIX B yrBep)KAeHHbrx perHcrparlfioHHbrx AoKyMeHTax. Ha
AasHufi
MoMeHT B HHcrpyKrIHH rro MeAHrIuHcKoMy npnMeHeHr,rro yKa3aHo, rrro He ncrpurrrfi
Qlarcon c
rpenaparoM cneAyer xpaHl{rb rIpH TeMneparype l5-30"C. OAHaro 6ruro ycraHoBJreHo, qro rrperapar
cneAyer xpaHI'ITb rIpI4 reMrleparype He Bbrrle 25"C. OOO <{xoucoH &
lxoncou>
npor.rHSopMlrpoBirno o6 erou @elepalrnyro Cnyx6y rro HaA3opy cSepe 3.qpasooxpaneHur.
Tarxe
6ruo rIoAaHo 3iuIBneHI'Ie s M[HucrepcrBo 34panooxpaneHur Ha BHeceHHe coorBercrBvroru'X
ugureHenufi
B
perucrparlr{oHHbre AoKyN{eHTbr.
o Eclu
yc|roBwfl, xpaneHut neKapcrBeHHoro [penapara
{aroreu He coorBercrByr.or ycnoBr{ro
o
KoJlnqecrBa Aerlu'ra6uHa B flpenapare lt rIoBbIIIreH[r Konl{qecrBa
[poAyKToB ero pi3noxeHgr.
Bo BHI{MaHI'Ie He6olsruyro [poAonxr.rreJrbHocrb xpaHeHrrr rrpe[apara
BHe cKJIaAa
KoMnaHI4H ooo
flpnnuMitt
lxoncoH>
rocrorHHrrfi roHrpo6
TeMneparypbl u TeMlleparypa [oAAepxHBaercr Hr{xe 25"C, BeporrHocrb
roro, r{To
neKapcrBeHuufi upenapar xpanl'ITcf, npu reMneparype, npeBbuuarcueft
25"C,Hn3Kuur.
r Ha ocHoBaHHI'I rpoBeAeHHoro aHaJrr.r3a BHyrpesuefi 6a:rr
AaHHbx OOO
Percorrengaqfin cneqfllurrcrau o6;racTrr 3ApaBooxpaHeH[s:
o flocrcolrry ooo
o
rIpI{ TeMrleparype Hltxe 25"C lo MoMeHTa AocraBKLI B MeAfirlr{HcKoe {axoreu
yqpexreg1ae r.rJrr.r B
aIITeKy' He oxl'IAaerct I'I3MeHeHHe Ha npo0unx 6egouacHocrr.r
neKapcrBeHuoro lpe[apara.
B roM cJlyr{ae, ecJIIr BsI He yBepeHbl, qro neKapcrseHHHft rrpelapar xpaHr.rnc,
np'
reMreparype He BbIIrIe 25oC rrarr [pocI.IM Bac csrgarrcs c OOO
<
(ren': +7 (495) 755-83-57, Sarc: +7 (495) 755-83-58)
arx .ur""r, neKapcrBeHHoro
tIpeuapara.
,{aunoe IIHcbMo ony6luronaHo no cofnacoBaHuro c OeAepalruoft Cnyx6oft no
HaA3opy n cQepe
3.qpasooxpaHeHns
Poccuftcxoft Oeaepaqur.r.
Horvrep re.ne$ona,r.nn
coo6qennft o HexeJrareJrbHbrx
fl
BJreH[sx
s o6ractn 3ApaBooxpalelvs. cneAyer coo6qarr o mo6rx HexeJrarenbHbx
tBJreHrrrx' cBr3aHHb\rNc
Cnequalxcrau
npHeMOM
121614, Mocxna,
(49s)
npelapara,{axoreH, s OOO <,,{xoHcoH &
!xoncoH>), pOCCl1g,
re.neQoubr: rerr.: +7 (4gS) 755-g3-57,
eaxc: +7
yl' $unarcrar, I i/2, not u*rnue
7s5-S3-s8 \\
flpn norHuxHoseHHu\bon
c ynaxeHueu, lf\ $
fleHncona H.A., \\\ J
o6parr{arrca no rereSoHy +7 (495) 755-g3-57
Meuegxep rtu
rvrlnvA^,l\sp
no ug3ollacHogJm
6eronac"on)d npeIIapaToB
OOO <{xoHcoH & nxon'oori>Limited Liability Company Johnson & Johnson
O6u{ecreo c orpaHhqeHHofi oreercraexHocrb|o <
MnxucrepcrBo sApaBooxpaneHnfl Poccnficrofi rDe4epaqun aE,[EPA]IbHAfl CJIy}I(SA IIO HAA3OPy B COEPE 3APABOOXPAHEHT,TS (POC3APABHA,TISOP) Cy6rerraM o6pauleHr.rt CJrassHcKa.s w. 4, crp. l, Mocxra, 109074 JIeKapcTBeHHbrx cpeAcTB Teaerlon: (495) 698 45 38;698 t5 74
Ne- /Czc - OT
O nerapcrneunoM cpeAcrBe <,{arcoren>
(De4epzurrnar cJryxda no HaA3opy B cQepe 3ApaBooxpa*enns, AoBoAur Ao cBeAeHI{t cy6seKToB o6palqeHl{rl JreKapcrBeHHbx cpeAcrB rr]rcbMo OOOAxoscoru c IlHQopMaIIEefi 06 ycJroBt4fx xpaHeHuf, Jrer(apcrBeHHoro npenapara (AaKoreH, ruo$uJll43ar AJII npriroroBJrenr,rr KoHrIeHTpara Arrfl npuroroBJreHr4.f, pacrBopa AJrf, r,rHoysuft 50 Mf).
flpznoxeHr.re: Ha I r. s I ers.
Bpuo pyKoBoAureJr.fl M.A.MyparrrKo
14.A.EnarlrHa 8 (499) s7802-19 fi HloHu 2013 KaraxcraH/Poccllc llpu.noxeune l.
llHQopnraql{oHnoe nucbMo AJrfl crrerlnaJrucroB s o6racru 3ApaBooxpaHeggfl Vc;ronus xpaHeHufl JrerapcrBeHuoro [pe[apara laxoreH I-{enrrc AaHHoro tIHcbMa r.Blrflercfl, npeAocraBneHr,re Bilr(Hoft uH{opuaqun o6 ycnoBgrx xpaHeHHt neKapcrBeHHoro [penapara AIrfl MeAr.rrIHHcKofo rtpHMeHeHHq laxoreH, .rruoSulurar AM rlpHroroBneHl,It KoHIIeHrpara Anr npr,rroroBreHr,rq pacrBopa 4nx r.ru$ysufi, 50 ur. HeAasHo OOO 6ula ycraHoBneHa Heo6xo4r,rMocrb yroqHeHr,rc ycnonnft xpaHeHr,rt AaHHOTO npelapara, yKa3aHHbIX B yrBep)KAeHHbrx perHcrparlfioHHbrx AoKyMeHTax. Ha AasHufi MoMeHT B HHcrpyKrIHH rro MeAHrIuHcKoMy npnMeHeHr,rro yKa3aHo, rrro He ncrpurrrfi Qlarcon c rpenaparoM cneAyer xpaHl{rb rIpH TeMneparype l5-30"C. OAHaro 6ruro ycraHoBJreHo, qro rrperapar cneAyer xpaHI'ITb rIpI4 reMrleparype He Bbrrle 25"C. OOO <{xoucoH &
npor.rHSopMlrpoBirno o6 erou @elepalrnyro Cnyx6y rro HaA3opy cSepe 3.qpasooxpaneHur.
lxoncou>
Tarxe 6ruo rIoAaHo 3iuIBneHI'Ie s M[HucrepcrBo 34panooxpaneHur Ha BHeceHHe coorBercrBvroru'X ugureHenufi B perucrparlr{oHHbre AoKyN{eHTbr.
o Eclu yc|roBwfl, xpaneHut neKapcrBeHHoro [penapara {aroreu He coorBercrByr.or ycnoBr{ro syulecrByer Bo3MoxHocrb cHr.rxeHu, KoJlnqecrBa Aerlu'ra6uHa B flpenapare lt rIoBbIIIreH[r Konl{qecrBa ero [poAyKToB pi3noxeHgr.
o flpnnuMitt Bo BHI{MaHI'Ie He6olsruyro [poAonxr.rreJrbHocrb xpaHeHrrr rrpe[apara BHe cKJIaAa KoMnaHI4H ooo lxoncoH> Ha KoropoM npoBoAuTcc rocrorHHrrfi roHrpo6 TeMneparypbl u TeMlleparypa [oAAepxHBaercr Hr{xe 25"C, BeporrHocrb roro, r{To neKapcrBeHuufi upenapar xpanl'ITcf, npu reMneparype, npeBbuuarcueft 25"C,Hn3Kuur.
r Ha ocHoBaHHI'I rpoBeAeHHoro aHaJrr.r3a BHyrpesuefi 6a:rr OOO AaHHbx flxoucou> He BHAHT Bo3Mo)KHoro r,rvraHat Ha npo$unr 6esonacHocru rrpelapara.
Percorrengaqfin cneqfllurrcrau o6;racTrr 3ApaBooxpaHeH[s:
o flocrcolrry ooo xpaHr.rnc, np'
reMreparype He BbIIrIe 25oC rrarr [pocI.IM Bac csrgarrcs c OOO <
(ren': +7 (495) 755-83-57, Sarc: +7 (495) 755-83-58) tIpeuapara.
arx .ur""r, neKapcrBeHHoro ,{aunoe IIHcbMo ony6luronaHo no cofnacoBaHuro c OeAepalruoft Cnyx6oft no HaA3opy n cQepe 3.qpasooxpaHeHns Poccuftcxoft Oeaepaqur.r.
Horvrep re.ne$ona,r.nn coo6qennft o HexeJrareJrbHbrx fl BJreH[sx Cnequalxcrau s o6ractn 3ApaBooxpalelvs. cneAyer coo6qarr tBJreHrrrx' cBr3aHHb\rNc npHeMOM npelapara,{axoreH, o mo6rx HexeJrarenbHbx s OOO <,,{xoHcoH & !xoncoH>), pOCCl1g, 121614, Mocxna, yl'
$unarcrar, I i/2, not u*rnue re.neQoubr: rerr.: +7 (4gS) 755-g3-57, +7 (49s) 7s5-S3-s8 \\ eaxc:
flpn norHuxHoseHHu\bon o6parr{arrca no rereSoHy +7 (495) 755-g3-57 c ynaxeHueu, lf\ $
fleHncona H.A., \\\ J Meuegxep rtu rvrlnvA^,l\sp 6eronac"on)d npeIIapaToB no ug3ollacHogJm OOO <{xoHcoH & nxon'oori>-
Limited Liability Company Johnson & Johnson O6u{ecreo c orpaHhqeHHofi oreercraexHocrb|o <
Ne- /Czc - OT
O nerapcrneunoM cpeAcrBe <,{arcoren>
(De4epzurrnar cJryxda no HaA3opy B cQepe 3ApaBooxpa*enns, AoBoAur Ao cBeAeHI{t cy6seKToB o6palqeHl{rl JreKapcrBeHHbx cpeAcrB rr]rcbMo OOO
flpznoxeHr.re: Ha I r. s I ers.
Bpuo pyKoBoAureJr.fl M.A.MyparrrKo
14.A.EnarlrHa 8 (499) s7802-19 fi
llHQopnraql{oHnoe nucbMo AJrfl crrerlnaJrucroB s o6racru 3ApaBooxpaHeggfl Vc;ronus xpaHeHufl JrerapcrBeHuoro [pe[apara laxoreH I-{enrrc AaHHoro tIHcbMa r.Blrflercfl, npeAocraBneHr,re Bilr(Hoft uH{opuaqun o6 ycnoBgrx xpaHeHHt neKapcrBeHHoro [penapara AIrfl MeAr.rrIHHcKofo rtpHMeHeHHq laxoreH, .rruoSulurar AM rlpHroroBneHl,It KoHIIeHrpara Anr npr,rroroBreHr,rq pacrBopa 4nx r.ru$ysufi, 50 ur. HeAasHo OOO
npor.rHSopMlrpoBirno o6 erou @elepalrnyro Cnyx6y rro HaA3opy cSepe 3.qpasooxpaneHur.
lxoncou>
Tarxe 6ruo rIoAaHo 3iuIBneHI'Ie s M[HucrepcrBo 34panooxpaneHur Ha BHeceHHe coorBercrBvroru'X ugureHenufi B perucrparlr{oHHbre AoKyN{eHTbr.
o Eclu yc|roBwfl, xpaneHut neKapcrBeHHoro [penapara {aroreu He coorBercrByr.or ycnoBr{ro
o flpnnuMitt Bo BHI{MaHI'Ie He6olsruyro [poAonxr.rreJrbHocrb xpaHeHrrr rrpe[apara BHe cKJIaAa KoMnaHI4H ooo
r Ha ocHoBaHHI'I rpoBeAeHHoro aHaJrr.r3a BHyrpesuefi 6a:rr OOO AaHHbx
Percorrengaqfin cneqfllurrcrau o6;racTrr 3ApaBooxpaHeH[s:
o flocrcolrry ooo
reMreparype He BbIIrIe 25oC rrarr [pocI.IM Bac csrgarrcs c OOO <
(ren': +7 (495) 755-83-57, Sarc: +7 (495) 755-83-58) tIpeuapara.
arx .ur""r, neKapcrBeHHoro ,{aunoe IIHcbMo ony6luronaHo no cofnacoBaHuro c OeAepalruoft Cnyx6oft no HaA3opy n cQepe 3.qpasooxpaHeHns Poccuftcxoft Oeaepaqur.r.
Horvrep re.ne$ona,r.nn coo6qennft o HexeJrareJrbHbrx fl BJreH[sx Cnequalxcrau s o6ractn 3ApaBooxpalelvs. cneAyer coo6qarr tBJreHrrrx' cBr3aHHb\rNc npHeMOM npelapara,{axoreH, o mo6rx HexeJrarenbHbx s OOO <,,{xoHcoH & !xoncoH>), pOCCl1g, 121614, Mocxna, yl'
$unarcrar, I i/2, not u*rnue re.neQoubr: rerr.: +7 (4gS) 755-g3-57, +7 (49s) 7s5-S3-s8 \\ eaxc:
flpn norHuxHoseHHu\bon o6parr{arrca no rereSoHy +7 (495) 755-g3-57 c ynaxeHueu, lf\ $
fleHncona H.A., \\\ J Meuegxep rtu rvrlnvA^,l\sp 6eronac"on)d npeIIapaToB no ug3ollacHogJm OOO <{xoHcoH & nxon'oori>-
Limited Liability Company Johnson & Johnson O6u{ecreo c orpaHhqeHHofi oreercraexHocrb|o <
Министерство здравоохранения Российской Федерации
ФЕДЕРАЛЬНАЯ СЛУЖБА ПО НАДЗОРУ [ |
В СФЕРЕ ЗДРАВООХРАНЕНИЯ
(РОСЗДРАВНАДЗОР) Субъектам обращения
Славянская пл. 4, стр. 1, Москва, 109074 лекарственных средств Телефон: (495) 698 45 38; 698 15 74
LEO F. ZL 02 № S06 te - 77/3
На № от
Г. |
О лекарственном средстве «Дакоген»
Федеральная служба по надзору в сфере здравоохранения доводит до сведения субъектов обращения лекарственных средств письмо ООО «Джонсон &
Джонсон» с информацией об условиях хранения лекарственного препарата «Дакоген, лиофилизат для приготовления концентрата для приготовления раствора для инфузий 50 мг».
Приложение: на | л. в 1 экз.
Врио руководителя es
М.А.Мурашко
и
и и и /
И.А.Елагина 8 (499) 578 02-19
ФЕДЕРАЛЬНАЯ СЛУЖБА ПО НАДЗОРУ [ |
В СФЕРЕ ЗДРАВООХРАНЕНИЯ
(РОСЗДРАВНАДЗОР) Субъектам обращения
Славянская пл. 4, стр. 1, Москва, 109074 лекарственных средств Телефон: (495) 698 45 38; 698 15 74
LEO F. ZL 02 № S06 te - 77/3
На № от
Г. |
О лекарственном средстве «Дакоген»
Федеральная служба по надзору в сфере здравоохранения доводит до сведения субъектов обращения лекарственных средств письмо ООО «Джонсон &
Джонсон» с информацией об условиях хранения лекарственного препарата «Дакоген, лиофилизат для приготовления концентрата для приготовления раствора для инфузий 50 мг».
Приложение: на | л. в 1 экз.
Врио руководителя es
М.А.Мурашко
и
и и и /
И.А.Елагина 8 (499) 578 02-19
Скачать документ: Письмо 16И-781/13 от 18.07.2013
Информационные письма Росздравнадзора по контролю качества: Лекарственные средства
Информационные письма Росздравнадзора по контролю качества: Медицинские изделия
Первая страница документа
